title: Clinical practice. Latent tuberculosis infection.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA. rjasmer@itsa.ucsf.edu
authors.forename: Robert M
authors.initials: RM
authors.lastname: Jasmer
authors.forename: Payam
authors.initials: P
authors.lastname: Nahid
authors.forename: Philip C
authors.initials: PC
authors.lastname: Hopewell
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D017410:Practice Guidelines as Topic; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014374:Tuberculin Test; D014376:Tuberculosis / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin